Home About Us Contact Us

Official Journals By StatPerson Publication

Table of Content - Volume 7 Issue 3 -September 2018


 

 

 

Randomized controlled study on comparative evaluation of 0.75% ropivacaine with 0.75% ropivacaine with dexmedetomidine in epidural anaesthesia in lower limb orthopaedic surgeries

 

Sreedevi Porika1, Patnana Pradeep Kumar2*

 

1Associate Professor, 2Post Graduate, Department of Anesthesiology, Gandhi Medical College, Padmarao Nagar, Secunderabad, Telangana, INDIA.

Email: doctorsreedevi@gmail.com

 

Abstract               Background: Regional anesthesia and analgesia has the potential to provide excellent operating conditions and prolongedpost operative pain relief. Epidural blockade is becoming one of the most useful and versatile procedures in modern anesthesiology. It is more versatile than spinal anesthesia. It can be used to supplement general anesthesia. It provides better postoperative pain control and more rapid recovery from surgery. Aim: To study the time of onset of action of ropivacaine0.75% and ropivacaine0.75% with Dexmedetomidine when administered epidurally. Materials and Methods: The prospective, randomized, comparative study was conducted on 60 patients aged between 18-55 years posted for lower limbsurgeries. Study compared the potentiating effects of epidurally administered dexmedetomidine when combined with Ropivacaine in terms of haemodynamic changes, onset of sensory and motor blockade, duration of analgesia, intra-operative haemodynamic changes and complications/adverse effects. Results: There was no significant difference in age, weight and height between the two groups. The early onset of sensory analgesia to T10 level and early onset of motor blockade in Group RD is statistically significant pvalue<0.05 (p value<0.0001).The time taken to reach the maximum level of sensory analgesia in Group RD was statistically significant p value<0.05(p value<0.0001). The delayed recovery of motor blockade in Group RD was statistically significant p value<0.05 (p value <0.0001).Duration of analgesia is prolonged in Group RD which is statistically significant p value<0.05 (p value<0.0001).There was no statistically significant difference in the pulserate, systolic blood pressure and diastolic blood pressure between the two groups. Conclusion: when dexmedetomidine 1mcg/kg added as adjuvant to 0.75% Ropivacaine in epidural anaesthesia in lower limb orthopaedic surgeries resulted in earlier onset of sensory analgesia to T10 level and helped in achieving the complete sensory anaesthetic level in a shorter period as compared to ropivacaine.

Key Words: ropivacaine, dexmedetomidine.

 

 

 

 

INTRODUCTION

Providing comfort to the patient byprevention and relief of pain and monitoring and maintenance of normalphysiology during the preoperative periodis the primary goalofan anesthetist.1 Regional anesthesia and analgesiahasthepotential to provide excellent operating conditions and prolonged postoperative painrelief.2 Epidural blockade is becoming one of the most useful and versatile procedures in modern anesthesiology. It is unique in that it can be placed atvirtually any level of the spine, allowing more flexibility in its application to clinical practice. It is more versatile than spinal anesthesia, giving the clinician the opportunity to provide anesthesia and analgesia, as well as enablingchronicpain management. It can be used to supplement general anesthesia, decreasing the need for deep levels of general anesthesia, therefore providing a more hemodynamically stable operative course. It provides better post operative pain control and more rapid recovery from surgery. For orthopaedic surgery, the provision of pain reliefenables early post operative mobilization acceleratesr ehabilitation and returntonormalfunction3. Aim of our study is to know the time of onset of actionofropivacaine0.75% and ropivacaine0.75% with Dexmedetomidine when administered epidurally and to study the duration of sensory and motor blockade, hemodynamic and respiratory effects and side effects by these drugs.

 

MATERIALS ANDMETHODS

A Prospective, randomized, double blind study was conducted on 60 patients of either sex (ASA I,II) between the age group of 18-55 yrs undergoing various lower limb orthopaedic procedures. Patients was randomly allocated into two groups of 30 patients each-GROUP R (Ropivacaine)-patients receiving 20 ml of 0.75% Ropivacaine 150mg epidurally n=30. GROUP RD (Ropivacaine with dexmedetomidine)-patients receiving 20ml of 0.75% Ropivacaine with dexmedetomidine 1mcg/kg. The study was conducted in Gandhi Hospital, Secunderabad after obtaining approval from institutional ethical committee. A written informed consent was obtained from each patient.Sixty patients aged between18 years and 55 years of (ASA I,II) of either sex undergoing lower limb orthopaedicsurgeries were included in the study.

Inclusion Criteria: Patients of age group 18-55 yrs of both sexe S, American society of Anaesthesiologists grade 1 and 2 physical status

Exclusion Criteria: Patients with age less than 18 yrs and more than 55 yrs, ASA III and IV. Pregnant woman, Any contraindications to epidural anaesthesia like hypotension, uncooperative patients, previous laminectomy, spine abnormality, Neurologic, cardiopulmonary or psychiatric disease, active liver, kidney disease. A Routine pre-anaesthetic was conducted on the evening day before surgery, assessing History and general condition of the patient Airway assessment by mallampati grading Nutritional status, height and weight of the patient A detailed examination of the cardiovascular system, respiratory system, central nervous system Examination of the spine. All patients in the inclusion criteria were visited on the previous day of surgery, and the procedure was explained to them. A detailed pre-anaesthetic examination was carried out and relevant investigations were advised. Baseline investigations were done in all patients. An informed valid written consent was taken from all the patients. premedication with Alprazolam 0.25mg and ranitidine 150mg was given orally the night before surgery. Patient was advised to maintain nil per oral status for 6 hrs. Pre-operatively pulse rate, Non-invasive systolic and diastolic blood pressure was recorded. In the operation room, a good intravenous access was secured and patients were preloaded with 20ml/kg body weight of Ringer lactate solution over 15-20 min. Multipara monitor was attached and baseline pulse rate, Non –invasive systolic blood pressure and diastolic blood pressure, oxygen saturation, ECG were recorded and monitoring was intiated.

Procedure: Patients were placed in sitting position and skin infiltration was given with 2ml of 2%lignocaine was performed. Then the epidural space was identified at L3-L4 inter space with a 18G Tuohy needle using the midline approach and a loss of resistance technique. After negative aspiration of blood,3ml of Lignocaine with 1:200000 Adrenaline test dose administered to exclude Intrathecal and intravascular placement of catheter. The study drug was given slowly in the epidural space over 2 min. All assessments were made by an anaesthesiologist who did not know the solution used. The study solution was revealed only at the end of the procedure.

Baseline pulse rate, systolic blood pressure and diastolic blood pressure were recorded. Pulse rate, systolic blood pressure, diastolic blood pressure every 5 min for the first 30 min, and there after every 15 min. Time to onset of sensory analgesia at T10 level. Time to onset and duration of Motor blockade, maximum level and duration of of sensory analgesia, Adverse effects and complications. Results were statistically analysed using unpaired t test and Fischer exact test. A p value <0.05 was considered as statistically significant. All the values are mentioned as mean standard deviation.

 

RESULTS

 

Table 1: Comparison of distribution between the two groups

Variables

GROUP R

GROUP RD

P VALUE

Age(yrs)

Mean

36.53

34.2

 

0.384

SD

10.80

9.79

Weight(kgs)

Mean

53.7

53.8

 

0.942

SD

5.618

5.026

Height(cms)

Mean

167.76

168.26

 

0.512

SD

2.635

3.215

Sex

Males

19

16

0.3119

 

Females

11

14

 

The average age in years was 36.53±10.80 in Group R and 34.2±9.79 in Group RD. There was no significant difference in age between the groups. The average weight in kgs in Group R was 53.7±5.618 and in Group RD was 53.8±5.026.There was no significant difference in weight between the groups and two groups were comparable. The average height in cms in Group R was 167.7±2.635 and in Group RD was 168.26±3.215.There was no significant difference in height between the groups and two groups were comparable. Both groups had predominantly male population.

 

Table 2: Variables on sensory and motor analgesia in two groups

Variables

 

GROUP R

GROUP RD

P VALUE

Time to onset of sensory analgesia to T10 Level(min)

Mean

13.36

10.6

0.0001

SD

2.498

1.428

Time to maximum level of sensory analgesia(min)

Mean

21.36

13.06

0.0001

SD

4.131

1.507

 

Maximum duration of

Sensory analgesia(min)

Mean

204.8

309.5

0.0001

 

SD

8.6

11

 

Time to onset of complete motor blockade(min)

Mean

22.7

15.26

0.0001

SD

3.70

1.46

 

Total duration of motor blockade(min)

Mean

133.9

215.86

0.0001

SD

7.60

10.40

 


The mean time to onset of sensory analgesia to T10 level is statistically significant (P value <0.05).The mean time to maximum level of sensory analgesia is statistically significant (P value <0.05). The mean to onset of complete motor blockade is statistically significant (P value <0.05).The mean time to total duration of motor blockade is statistically significant (P value<0.05). Mean time to maximum duration of sensory analgesia is statistically significant (P value<0.05).

 

Figure 1: Highest level of sensory blockade

In patients of Ropivacaine group (Group R) 6% patients attained T4 level, 13%attained T5 level,43% attained T6 level,10% attained T7 level,13% attained T8 level, 13% attained T10 level. In patients of Ropivacaine and dexmedetomidine (Group RD) 43% attained T4 level,36.8% attained T5 level, 10% attained T6 level, 3% attained T7 level,6% attained T8.This implied that there was significant difference in highest level of sensory blockade compared in the two groups.


Figure 2: Comparison of pulse rate (beats per min) in the two groups

 

The mean pulse rate was compared between the two groups Group R and Group RD at 0,5,10,15,20,25,30,45,60,75,90,105,120,150 and 180 mins. There was no statistically significant difference between the two groups with respect to pulse rate when recorded at these time intervals.

Figure 3: Comparison of systolic blood pressure (mm of Hg) changes in two groups-

The mean systolic blood pressure changes over the time intervals was compared between the two groups Group R and Group RD. It was found that systolic blood pressure did not differ between the groups.

 

Figure 4: Comparison of diastolic blood pressure (mm of Hg) changes in two groups-

 


The mean diastolic blood pressure changes over the time intervals was compared between the two groups Group R and Group RD. It was found that diastolic blood pressure did not differ between the groups.

Adverse effects: In Ropivacaine group, 2 patients had nausea, and 2 patients had hypotension out of 30 during the intraoperative period. In Group RD 2 patients had nausea, 1 patient had  hypotension, 2 patients had bradycardia out of 30 during the intraoperative period.

DISCUSSION

Epidural Anaesthesia and analgesia is considered by many as the gold standard technique for major surgery. It has the potential to provide complete analgesia for as long as the epidural is continued. Epidural techniques are particularly effective at providing dynamic analgesia, allowing the patient to mobilise and resume normal activities unlimited by pain. It also improves the postoperative outcome and attenuates the physiological response to surgery, in particular, significant reduction in pulmonary infections, pulmonary embolism, ileus, acute renal failure and blood loss.4Previously Bupivacaine is a well established long acting local amide local anaesthetic which has been in use since 1957.It has been the most popular and widely used local anaesthetic agent for long surgical procedures. It is used to provide Intraoperative anaesthesia by intrathecal, epidural and caudal route, nerve blocks, field blocks, labour analgesia, postoperative analgesia. The major disadvantage is its potential for cardiotoxicity. A number of deaths have been reported due to cardiac arrest from regional anaesthesia with bupivacaine which appear due to inadvertent intravascular injection of drug. These deaths and subsequent recommendations of the food and drug administration provided the impetus to develop a new safer local anaesthetic.5 Ropivacaine is a long acting regional anaesthetic which has been developed for the purpose of reducing the potential toxicity associated with Bupivacaine. It is developed as a pure S(-) enantiomer. R and S enantiomers of local anaesthetics have been demonstrated to have a different affinity for the different ion channels of calcium, potassium, sodium channels which results in a significant reduction of CNS and cardiac toxicity of the S (-) enantiomer to R (+) enantiomers. Ropivacaine is less lipophillic than bupivacaine and is less likely to penetrate the large myelinated motor fibres resulting in a relatively reduced motor blockade. Thus it has a greater degree of motor and sensory differentiation which is useful when motor blockade is undesirable.6 Various adjuvants are being used with local anaesthetics for prolongation of intraoperative and postoperative analgesia in epidural block for lower limb orthopaedic surgeries and to minimize the adverse effects of high doses of local anaesthetics. The aipha 2 adrenergic agonists have analgesic properties when used as a adjuvant in regional anaesthesia. Dexmedetomidine, a newer and highly selective alpha 2 adrenergic agonist has evolved. The stable hemodynamics and the decreased oxygen demand due to enhanced sympathoadrenal stability make it a very useful adjuvant. The present study was conducted in the deparment of anaesthesiology at Gandhi hospital Musheerabad, secunderabad. In the present study the patients studied in the two groups did not vary much with respect to age, sex or weight and height. Majority of patients were in the age group between 18-55 yrs,with the mean age in yrs was 36.53±10.80 in Group R and 34.2±9.79 in Group RD. The mean sex distribution and the mean weight in the two groups were also identical. These parameters were matched in the two groups to avoid changes in intraoperative and postoperative outcome of patients. The average weights of the patients in Group R was 53.7±5.618 and in Group RD was 53.8±5.026.There was no significant difference in weight between the groups and two groups were comparable. The average height in cmsin Group R was 167.76±2.635 and in Group RD was 168.26±3.215.There was no significant difference in height between the groups and two groups were comparable.

Time to onset of sensory analgesia to T10 level-

The mean time to onset of sensory analgesia to T10 level in Group R was 13.36±2.498 and in Group RD was 10.6±1.428.The early onset of sensory analgesia to T10 level in Group RD is statistically significant P value was <0.05 (0.0001).A prospective, randomized double blinded study was conducted by Giri and Iqbal7,which included 60 adult patients, Addition of dexmedetomidine to ropivacaine as an adjuvant resulted in an earlier onset (8.52±2.36 minutes) of sensory analgesia at T10 level as compared to the ropivacaine alone (9.72±3.44 minutes).The difference was statistically significant.The results of these studies are in accordance to present study and comparable with our study.Bajwa et al8,conducted prospective randomized study was carried out which included 50 adult female patients between ages (44-65 yrs) the results of these studies are comparable with our study.Dexmedetomidine group has earlier onset compared to clonidine group.The difference was statistically significant.Bajwa et al9,conducted prospective double blinded study on 100 patients of both gender aged (21-56yrs) Group RD had earlier onset of analgesia to T10 level compared to Group RF (7.12±2.44) vrs(9.14±2.94) the difference was statistically significant. This observation matches well with our study.

Time to maximum level of sensory analgesia: The mean time to maximum level of sensory analgesia in Group R was 21.36±4.131,and in Group RD was 13.06±1.507.The early onset to maximum level of sensory analgesia in Group RD is statistically significant p value<0.05(0.0001).In Group RD there is maximum sensory block level compared to Ropivacaine group. Bajwa et al8,conducted prospective randomized study was carried out which included 50 adult female patients between ages (44-65 yrs) ASA I,II who underwent vaginal hysterectomies. In Group RD the time to maximum sensory block level is( 13.14±3.96) vrs(15.80±4.86) and also maximum sensory block level in dexmedetomidine group compared to clonidine group which is statistically significant. This observation matches well with our study. Thimmappa et al10, conducted a comparative study of epidural ropivacaine 0.75% alone with ropivacaine+clonidine and ropivacaine+dexmedetomidine for lower abdominal and lower limb surgeries. They conducted on 90 patients (ASA I,II) of age group 18-55 yrs of either sex. Group RD-19ml of 0.75% ropivacaine with 75mcg dexmedetomidine and observed that the time to maximum sensory block level was faster in Group RD compared to Group RC and Group R (13.03±1.33) vrs (13.63±1.96) vrs (16.00±1.78) which are statistically significant.

Time to onset of complete motor blockade: The mean time to onset of complete motor blockade in Ropivacaine (Group R) was 22.7±3.70 min and in Ropivacaine and dexmedetomidine (Group RD) was 15.26±1.46 min. The mean to onset of complete motor blockade is statistically significant in Group RD compared to Group R.P value <0.05 (0.0001). Bhawana Rastogi et al11,conducted a study by adding dexmedetomidine as an adjuvant to epidural 0.75% Ropivacaine in patients undergoing infraumbilicalsurgery. They conducted a study on 80 patients of 18-58 yrs of age of either sex had complete motor block in minutes(17.20±4.10 vrs 23.90±3.57) was significantly earlier in the ropivacaine with dexmedetomidinegroup. This observation matches well with our study. Thimmappa et al10, conducted a comparative study of epidural ropivacaine 0.75% alone with ropivacaine+clonidine and ropivacaine+dexmedetomidine for lower abdominal and lower limb surgeries. They conducted on 90 patients (ASA I,II) of age group 18-55 yrs of either sex. Group RD-19ml of 0.75% ropivacaine with 75mcg dexmedetomidine and observed that establishment of complete motor block was earlier in Group RD (15.77±1.25 min) compared to Group RC(16.47±1.38 min) and Group R (21.37±2.13 min) which shows statistically significant. This observation supports the present study. Bajwa et al8, conducted prospective randomized study was carried out which included 50 adult female patients between ages (44-65 yrs) showed onset time to complete motor block in Group RD was 17.24±5.16 min and in Group RC was 19.52±4.06 min, dexmedetomidine group had earlier onset of complete motor blockade compared to clonidine. This observation supports the present study.

Total duration of motor blockade: The mean time to total duration of motor blockade in Group R was 133.9±7.60 minand in Group RD was 215.86±10.40 min. The mean time to total duration of motor blockade is statistically significant p value<0.05(0.001).Thimmappa et al10, conducted a comparative study of epidural ropivacaine 0.75% alone with ropivacaine+clonidine and ropivacaine+dexmedetomidine for lower abdominal and lower limb surgeries. They conducted on 90 patients. Group RD-19ml of 0.75% ropivacaine with 75mcg dexmedetomidine and observed that total duration of motor blockade was delayed in Group RD-213.83±17.30,and in Group RC-165.63±14.73 and in Group R-132.37±12.59 minutes. Total duration of motor blockade is prolonged in dexmedetomidine group which is statistically significant. This observation supports the present study. Sarabjitkaur et al12, conducted a prospective randomized blinded study by adding dexmedetomidine as an adjuvant to 0.75% Ropivacaine in epidural anaesthesia in lower limb orthopaedic surgeries. They conducted in 100 patients of ASA (I, II) age group (20-65) yrs of either sex undergoing lower limb surgeries. Group RD-150mg of 0.75%Ropivacaine with dexmedetomidne 1mcg/kg. Motor recovery was delayed in Group RD 385.92±17.71 minutes compared to Group R 259.80±15.48 minutes which shows statistically significant. This observation supports the present study. Bhawana Rastogi et al11,conducted a study by adding dexmedetomidine as an adjuvant to epidural 0.75% Ropivacaine in patients undergoing infraumbilical surgery. They conducted a study on 80 patients of 18-58 yrs of age of either sex observed that duration of motor blockade was 185.38±23.24 minutes in Group R and in Group RD was 362.13±72.9 minutes which is statistically significant, the results was in accordance to the present study

Maximum duration of sensory analgesia: The mean time to maximum duration of sensory analgesia in Group R was 204.8±8.6 minutes and in Group RD was 309.5±11 minutes. The mean time to maximum duration of sensory analgesia is statistically significant p value<0.05(0.0001). Sarabjitkaur et al12, conducted a prospective randomized blinded study by adding dexmedetomidine as an adjuvant to 0.75% Ropivacaine in epidural anaesthesia in lower limb orthopaedic surgeries. They conducted in 100 patients of ASA (I, II) age group(20-65) yrs of either sex undergoing lower limb surgeries. They observed that total duration of sensory block in Group R was 375.20±15.97 minutes and in Group RD was 535.18±19.85 minutes which shows statistically significant. This observation matches well with our study. Bhawana Rastogi et al11,conducted a study by adding dexmedetomidine as an adjuvant to epidural 0.75% Ropivacaine in patients undergoing infraumbilicalsurgery. They conducted a study on 80 patients of 18-58 yrs of age of either sex they observed that duration of analgesia in Group R was 216.58±25.5 minutes and in Group RD was 429.25±90.4 minutes which shows statistically significant results.This observation matches well with our study. Thimmappa et al10, conducted a comparative study of epidural ropivacaine 0.75% alone with ropivacaine+clonidine and ropivacaine+dexmedetomidine for lower abdominal and lower limb surgeries. They conducted on 90 patients (ASA I,II) of age group 18-55 yrs of either sex observed that duration of analgesia is prolonged in Group RD (291.33±27.79 minutes) compared to Group RC (261±17.68 minutes) and Group R (200.33±17.07 minutes) which shows statistically significant results. This observation matches well with our study.

Haemodynamic Parameters: In present study, baseline hemodynamic parameters were observed before giving the Epidural anaesthesia and for every 5 min for the first 30 min and thenevery15 mintill the end of surgery. It was observed that the changes in pulserate, systolic blood pressure and diastolic blood pressure throughout the intraoperative periodwas notclinically and statistically significant. Two patients out of thirty patients in Group R and one patient out of thirty in Group RD were observed to hypotension in the intra-operative period. The hypotension was responsive to fluid bolus and vasopressors. Salgado et al13, conducted a study by adding dexmedetomidine as an adjuvant to 0.75%ropivacaine.They conducted on 40 patients scheduled for hernia repair, varicose vein surgeries under epidural anaesthesiathey observed that there was no statistically significant difference in heart rate, non invasive systolic blood pressure, diastolic blood pressure. This observation matches well with our study. Sarabjitkaur et al12, conducted a prospective randomized blinded study by adding dexmedetomidine as an adjuvant to 0.75% Ropivacaine in epidural anaesthesia in lower limb orthopaedic surgeries they observed that there was no statistically significant difference in heart rate, non invasive systolic blood pressure and diastolic blood pressure.

CONCLUSION

From our study, we conclude that when dexmedetomidine 1mcg/kg added as adjuvant to 0.75% Ropivacaine in epidural anaesthesia in lower limb orthopaedic surgeries the following effects are seen-Addition of dexmedetomidine to ropivacaineas an adjuvant resulted in earlier onset of sensory analgesia to T10 level as compared to ropivacaine group Group R. Dexmedetomidine provided a higher dermatomal spread and also helped in achieving the complete sensory anaesthetic level in a shorter period in comparison to Ropivacaine alone. Group R Complete motor blockade was also achieved earlier in dexmedetomidine group Group RD in comparison to Ropivacaine Group R.Dexmedetomidine also increased the total duration of sensory analgesia in comparison to Ropivacaine group R. Duration of motor blockade is less in Ropivacaine( Group R) as compared to Ropivacaine and dexmedetomidine (Group RD).

 

 

 

REFERENCES

  1. G Edward Morgan, Maged S Mikhail, Michael J Murray. The practice of Anesthesiology. Clinical Anesthesiology. 4th ed. McGrawHill,2008;l-l6
  2. NJH Davies, IN Cashman. Techniques in regional Anaesthesia. Lee’s Synopsis of Anaesthesia. 13th ed. Elsevier, 2006;401-70.
  3. Admirhadzic. Regional Anaesthesia and acute pain management. lstEdn. McGraw-Hill Professional, 2006.
  4. Susan M Nimmo. Benefit and outcome after epidural analgesia. Continuing Education in Anaesthesia, critical care and pain 2004;4(2):44-7
  5. V A Peduto, S Baroncini, S Montanini, R Proietti, L Rosignoli, R Tufano et al. A prospective, randomized, double-blind comparison of epidural Levobupivacaine 0.5% with epidural Ropivacaine 0.75% for lower limb procedures. Eur J Anaesthesiogy2003; 20:979-83.
  6. Ankit Agarwal, R K Verma, Shivika Srivastava. Ropivacaine- The latest local anaesthetic in Indian market. J AnaesthClinPharmacol 2010;26(2):22328
  7. Ravindra S. Giri, Mukarram Iqbal, dexmedetomidine for lower abdominal and lower limb surgeries. V care for life sciences journal, Volume 3, Issue 2, ISSN: 2231- 9522, p55-
  8. Bajwa SJBajwa SKKaur JSingh GArora VGupta SKulshrestha ASingh AParmar SSingh AGoraya S. Dexmedetomidine and clonidine in epidural anaesthesia: A comparative evaluation. Indian Journal Of Anaesthesia 2011 Mar; 55(2):116-21.
  9. S.J. Singh Bajwa, Vikramjit Arora, Jasbir Kaur, Amarjit Singh, S.S.Parmar. Comparative evaluation of dexemdetomidine and fentanyl for epidural analgesia in lower limb orthopaedic surgeries. Bajwa SJ, Arora V, Kaur J, Singh A, Parmar SS. Saudi J Anaesth. 2011 Oct; 5(4):365-70.
  10. ManjunathThimmappa, Ravi Madhusudhana, SomasekharamPotli, Dinesh Karthick. A Comparative Study Of Epidural Ropivacaine 0.75% Alone With Ropivacaine Plus Clonidine And Ropivacaine Plus Dexmedetomidine For Lower Abdominal And Lower Limb Surgeries. World Journal Of Pharmacy And Pharmaceutical Sciences Volume 3, Issue 4, 1218-1230.
  11. BhawanaRastogi, VP singh, DeeptiMangla, Kumkumgupta, Manish jain and MN Pandey. Dexmedetomidine as an adjuvant to epidural 0.75% ropivacaine in patients undergoing infraumbilical surgery: a clinical study. Global Anesthesia and Perioperative Medicine 2015, Volume 1(1): 19-23
  12. Sarabjit Kaur, Joginder Pal Attri, Gagandeep Kaur, Tejinder Pal Singh. Comparative evaluation of ropivacaine versus dexmedetomidine and ropivacaine in epidural anaesthesia in lower limb orthopaedic surgeries. Saudi Journal of Anesthesia, October-December 2014, volume 8, issue 4, p463-469.
  13. Salgado PFSabbag ATSilva PCBrienze SLDalto HPMódolo NSBraz JRNascimento P Jr.Synergistic effect between dexmedetomidine and 0.75% ropivacaine in epidural anesthesia. Rev Assoc Med Bras (1992). 2008 Mar-Apr; 54(2):110-5.